An in vitro method for predicting the sensitivity of tumor growth to inhibition by an EGFR kinase inhibitor, comprising cells: assessing the level of an epithelial biomarker expressed by a tumor cell; assessing the level of a mesenchymal biomarker expressed by a tumor cell; and predicting the sensitivity of development of tumor inhibition cells by an inhibitor of EGFR kinase, wherein a high ratio of expression levels of epithelial to mesenchymal biomarker correlates with high sensitivity to inhibition by inhibitors EGFR kinase.
展开▼